Mo Ziari
Biography
Mo Ziari, M.D., is Clinical Professor in the Division of Hematology/Oncology and Director of the UCI Health Community Cancer Network at the University of California, Irvine. He also serves as Director of Infusion at the Chao Family Comprehensive Cancer Center. Prior to joining UCI in 2023, Ziari spent nearly a decade at City of Hope Medical Center in Corona, where he served as Assistant Clinical Professor and Staff Physician in the Department of Medical Oncology, and also held the position of Residency Program Coordinator. Earlier in his career, he served as Chief of Hematology-Oncology at Riverside County Regional Medical Center.
Ziari received his medical degree from Shiraz University of Medical Sciences in Iran and completed his post-doctoral fellowship in Hematology-Oncology at Baylor College of Medicine. He subsequently completed his internal medicine residency at Saint Louis University School of Medicine and Forest Park Hospital, followed by a fellowship in Hematology and Medical Oncology at UT Southwestern Medical Center in Dallas. He is board certified in Internal Medicine, Medical Oncology, and Hematology.
Ziari serves as co-investigator on numerous multi-center clinical trials through cooperative groups including Alliance, ECOG-ACRIN, and SWOG, focusing on breast cancer, lung cancer, colorectal cancer, and gastric cancers. His research portfolio includes trials evaluating targeted therapies, immunotherapies, and novel combination treatments across various malignancies. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and serves on advisory boards for Pfizer and Alexion Pharmaceuticals.
Return to topEducation
- M.D., Shiraz University of Medical Sciences, 1995
- Fellowship in Hematology & Medical Oncology, UT Southwestern Medical Center, 2010
- Residency in Internal Medicine, Saint Louis University School of Medicine, 2007
Areas of Expertise
- Hematology and Medical Oncology
- Neutropenic Fever Management
- Heparin-Induced Thrombocytopenia Diagnosis
- Thrombocytopenia in Cancer Patients
- HER2-Amplified Gastrointestinal Malignancies
- Targeted Therapy for Lung Cancer
- Community Cancer Network Development
Recent Publications
- Salgia NJ, Philip EJ, Ziari M, Yap K, Pal SK, “Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices” (opens in new tab), J Clin Med, vol. 9, no. 5, pp. 1508, 2020.
- Mohammad Ziari, Catherine Burke, Karen Matevosyan, Eugene P. Frenkel, Ravindra Sarode, Yu-Min Shen, “Optical Density of 1.0 Is a Better Cutoff for Positive HIT Ab ELISA” (opens in new tab), Blood (ASH Annual Meeting Abstracts), vol. 114, pp. Abstract 3515, 2009.
- Mohammadbagher Ziari, Ganesj Kudva, Luis Salinas-Madrigal, Cherise Cortese, Paul Garvin, Medhat Osman, Bahar Bastani, “Late Occurrence of Malignant Post-Transplant Lymphoproliferative Disorder (PTLD) presenting with Severe Acute Renal Failure”, Dialysis & Transplantation, vol. 36, no. 5, pp. 276-282, 2007.
- Tan A, Ziari M, Salman H, Ortega W, Cortese C, “Spontaneous Rupture of the Spleen in the Presentation of Acute Myeloid Leukemia”, Journal of Clinical Oncology, vol. 25, no. 34, 2007.
- Mohammadbagher Ziari, Bin S Teh, Steven Shen, Robert Amato, “Metastatic Renal Cell Carcinoma to the Nose and Ethmoid Sinus”, Journal of Urology, 2005.
- Mohammadbagher Ziari, Guru Sonpavde, Steven Shen, Bin S The, Tung Shu, Seth P Lerner, “Small Cell Carcinoma of the Urinary Bladder” (opens in new tab), Journal of Clinical Oncology, vol. 23, no. 19, pp. 4458-4459, 2005.
- Mohammadbagher Ziari, Guru Sonpavde, Steve Shen, Bin Teh, Jim Zhai, Seth P Lerner, “Rhabdomyosarcoma of the Urinary Bladder in an Adult” (opens in new tab), Journal of Clinical Oncology, vol. 23, no. 19, pp. 4459-4460, 2005.
- Ardeshir Torab, Mohammadbagher Ziari, “Relationship between high Hematocrit and Myocardial Infarction”, Blood Transfusion Organization Journal, pp. 38-41, 2001.
This profile was created with the help of AI.
Last updated on 5/19/2026.